Market News

Cvs Health (CVS) Holder Farr Miller & Washington Trimmed Its Position by $846,864 as Share Value Declined; Cortland Advisers Decreased Its Chevron (CVX) Stake by $10.99 Million

Chevron Corporation (NYSE:CVX) Logo

Farr Miller & Washington Llc decreased its stake in Cvs Health Corp (CVS) by 2.69% based on its latest 2017Q4 regulatory filing with the SEC. Farr Miller & Washington Llc sold 11,762 shares as the company’s stock declined 17.45% with the market. The institutional investor held 425,902 shares of the medical and nursing services company at the end of 2017Q4, valued at $30.88M, down from 437,664 at the end of the previous reported quarter. Farr Miller & Washington Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $66.00B market cap company. The stock decreased 1.28% or $0.84 during the last trading session, reaching $64.92. About 4.73M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 20, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Cortland Advisers Llc decreased its stake in Chevron Corp (CVX) by 7.41% based on its latest 2017Q4 regulatory filing with the SEC. Cortland Advisers Llc sold 87,953 shares as the company’s stock declined 8.26% with the market. The institutional investor held 1.10M shares of the integrated oil company at the end of 2017Q4, valued at $137.68 million, down from 1.19M at the end of the previous reported quarter. Cortland Advisers Llc who had been investing in Chevron Corp for a number of months, seems to be less bullish one the $244.34 billion market cap company. The stock decreased 1.24% or $1.6 during the last trading session, reaching $127.86. About 6.39 million shares traded. Chevron Corporation (NYSE:CVX) has risen 7.88% since May 20, 2017 and is uptrending. It has underperformed by 3.67% the S&P500.

Since April 17, 2018, it had 0 insider buys, and 8 sales for $48.52 million activity. On Tuesday, April 17 Pate R. Hewitt sold $3.11 million worth of Chevron Corporation (NYSE:CVX) or 25,500 shares. Yarrington Patricia E sold $17.55 million worth of stock or 135,000 shares. $3.26 million worth of Chevron Corporation (NYSE:CVX) was sold by Breber Pierre R. Wirth Michael K also sold $16.64M worth of Chevron Corporation (NYSE:CVX) shares.

Investors sentiment increased to 0.99 in Q4 2017. Its up 0.04, from 0.95 in 2017Q3. It improved, as 51 investors sold CVX shares while 686 reduced holdings. 122 funds opened positions while 608 raised stakes. 1.19 billion shares or 0.58% more from 1.18 billion shares in 2017Q3 were reported. Bbva Compass State Bank holds 0.43% of its portfolio in Chevron Corporation (NYSE:CVX) for 53,665 shares. Summit Grp Inc Ltd Liability has 3,300 shares. Meeder Asset Management holds 0.68% of its portfolio in Chevron Corporation (NYSE:CVX) for 63,517 shares. Jacobs Levy Equity reported 0.48% stake. Intrust Bank & Trust Na holds 1.35% in Chevron Corporation (NYSE:CVX) or 36,077 shares. Norinchukin Fincl Bank The holds 0.75% of its portfolio in Chevron Corporation (NYSE:CVX) for 343,137 shares. Bridgeway Management invested in 116,723 shares. Eagle Asset Management Inc holds 0.48% of its portfolio in Chevron Corporation (NYSE:CVX) for 732,715 shares. Fin Advisory Gp stated it has 0.15% in Chevron Corporation (NYSE:CVX). Hussman Strategic Advisors holds 25,000 shares or 0.89% of its portfolio. Moody Bank Division has 0.17% invested in Chevron Corporation (NYSE:CVX) for 29,380 shares. Kepos LP has 0.45% invested in Chevron Corporation (NYSE:CVX). Moreover, Tocqueville Asset Management LP has 0.49% invested in Chevron Corporation (NYSE:CVX) for 345,687 shares. Vaughan David Investments Il holds 1.31% of its portfolio in Chevron Corporation (NYSE:CVX) for 226,279 shares. Creative Planning stated it has 0.15% in Chevron Corporation (NYSE:CVX).

More notable recent Chevron Corporation (NYSE:CVX) news were published by: Seekingalpha.com which released: “Chevron: A Dividend Stock I’ll Never Buy” on May 17, 2018, also 247Wallst.com with their article: “How Higher Prices and Production Lifted Chevron Earnings” published on April 27, 2018, Seekingalpha.com published: “Chevron Impresses In The Permian” on May 11, 2018. More interesting news about Chevron Corporation (NYSE:CVX) were released by: Seekingalpha.com and their article: “Chevron seeks shared development of Australia’s Carnarvon basin” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “Chevron: I Was Wrong” with publication date: May 07, 2018.

Analysts await Chevron Corporation (NYSE:CVX) to report earnings on July, 27. They expect $1.87 EPS, up 105.49% or $0.96 from last year’s $0.91 per share. CVX’s profit will be $3.57 billion for 17.09 P/E if the $1.87 EPS becomes a reality. After $1.90 actual EPS reported by Chevron Corporation for the previous quarter, Wall Street now forecasts -1.58% negative EPS growth.

Among 35 analysts covering Chevron Corporation (NYSE:CVX), 26 have Buy rating, 0 Sell and 9 Hold. Therefore 74% are positive. Chevron Corporation had 122 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, March 18 by Nomura. The firm earned “Buy” rating on Friday, June 23 by Jefferies. RBC Capital Markets maintained it with “Sell” rating and $115.0 target in Tuesday, January 30 report. The firm has “Buy” rating by Piper Jaffray given on Monday, February 5. The stock of Chevron Corporation (NYSE:CVX) earned “Neutral” rating by UBS on Monday, August 3. Barclays Capital maintained it with “Overweight” rating and $145 target in Monday, April 30 report. The stock of Chevron Corporation (NYSE:CVX) earned “Outperform” rating by Credit Agricole on Tuesday, December 15. Barclays Capital upgraded the shares of CVX in report on Tuesday, February 6 to “Overweight” rating. Morgan Stanley upgraded the shares of CVX in report on Tuesday, November 1 to “Overweight” rating. The firm has “Underperform” rating by Macquarie Research given on Wednesday, September 23.

Farr Miller & Washington Llc, which manages about $1.04 billion and $1.12B US Long portfolio, upped its stake in Bb&T Corp (NYSE:BBT) by 6,686 shares to 488,623 shares, valued at $24.29M in 2017Q4, according to the filing.

Since February 16, 2018, it had 2 insider purchases, and 1 sale for $713,454 activity. BROWN C DAVID II bought 10,000 shares worth $619,900. Another trade for 24,300 shares valued at $1.51M was bought by DORMAN DAVID W.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 earnings per share, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64 billion for 10.08 P/E if the $1.61 EPS becomes a reality. After $1.48 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Fool.com which released: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” on May 04, 2018, also Fool.com with their article: “Why CVS Health Stock Gained 12% in April” published on May 08, 2018, Seekingalpha.com published: “We Are Playing The CVS Hand” on May 11, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: 247Wallst.com and their article: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” published on April 29, 2018 as well as Seekingalpha.com‘s news article titled: “CVS: Going Long, And Understanding The Aetna Deal” with publication date: April 30, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *